Covid-19 | Page 3 of 100 | Links Medicus Content Curation & Alerts in Medicine

Excess mortality among US physicians during the COVID-19 pandemic

16 Feb, 2023 | 15:14h | UTC

Excess Mortality Among US Physicians During the COVID-19 Pandemic – JAMA Internal Medicine

Commentaries:

More than 600 US doctors died than expected early in COVID pandemic – CIDRAP

Hundreds of U.S. Doctors Lost Their Lives During Pandemic – HealthDay

Commentary on Twitter

From March 2020 to December 2021, US physicians experienced over 600 more deaths than expected, but substantially fewer than the US general population. Older physicians who provide direct patient care were at the highest risk. https://t.co/7Un0h7VC8X

— JAMA Internal Medicine (@JAMAInternalMed) February 8, 2023

Cohort Study | Incidence of acute cardiac events during COVID-19-associated hospitalizations

15 Feb, 2023 | 16:05h | UTC

Acute Cardiac Events During COVID-19-Associated Hospitalizations – Journal of the American College of Cardiology

Editorial: Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease – Journal of the American College of Cardiology

RCT | Pegylated Interferon Lambda reduces hospitalizations in predominantly vaccinated outpatients with Covid-19

9 Feb, 2023 | 14:03h | UTC

Early Treatment with Pegylated Interferon Lambda for Covid-19 – New England Journal of Medicine

News Release: Single-dose treatment reduces risk of COVID-19 hospitalization by half for high-risk patients in a largely vaccinated population – University Health Network

RCT | BCG vaccine not effective for preventing COVID-19 and other respiratory tract infections in older adults

9 Feb, 2023 | 13:53h | UTC

Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial – Clinical Microbiology and Infection

News Release: Tuberculosis vaccine does not protect elderly against COVID-19, finds large Dutch study – University Medical Center Utrecht

Commentary on Twitter

Bacillus Calmette-Guérin vaccine in ineffective in prevention of COVID-19 and other respiratory tract infections in older adults with comorbiditieshttps://t.co/dS4h1bq3Ns

— Clinical Microbiology and Infection (@CMIJournal) February 1, 2023

Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19

9 Feb, 2023 | 13:50h | UTC

Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19 – Clinical Infectious Diseases

Review | Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome

8 Feb, 2023 | 12:38h | UTC

Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome – Nature Reviews Cardiology

Commentary on Twitter

In our latest Comment, Fedorowski & Sutton discuss the role of autonomic dysfunction and postural orthostatic tachycardia syndrome (POTS) in post-acute #COVID19 syndrome: https://t.co/gJ08XxnfQ6 pic.twitter.com/FmC9JwDs4C

— Nature Reviews Cardiology (@NatRevCardiol) February 2, 2023

Opinion | Let’s do the Cochrane review of physical measures to reduce the spread of viruses

7 Feb, 2023 | 14:11h | UTC

Let’s Do the Cochrane Review of Physical Measures to Reduce the Spread of Viruses – Sensible Medicine

Original Study: SR | Physical interventions to interrupt or reduce the spread of respiratory viruses

RCT | Paxlovid did not improve outcomes in hospitalized patients with Covid-19

7 Feb, 2023 | 14:08h | UTC

Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study – The Lancet Regional Health Western Pacific

M-A | Heparin full-dose anticoagulation is beneficial for non-critically ill COVID-19 patients

7 Feb, 2023 | 14:06h | UTC

The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies – Lung

#ESCCongress | In critically ill patients with COVID-19, full-dose anticoagulation reduced thrombotic events but increased the risk of bleeding.

Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials – Journal of Thrombosis and Thrombolysis

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis – Open Forum Infectious Diseases

Point/Counterpoint: Should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19?

Opinion | Hospital masking should be optional

6 Feb, 2023 | 13:37h | UTC

Hospital masking should be optional – Sensible Medicine

Case-control study | Estimation of vaccine effectiveness of CoronaVac and BNT162b2 in patients with SARS-CoV-2 Omicron

6 Feb, 2023 | 13:32h | UTC

Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron – JAMA Network Open

Commentary on Twitter

The CoronaVac and BNT162b2 (Pfizer) vaccines were effective against severe outcomes due to Omicron (74-77%), but protection among older individuals in Hong Kong was more likely to wane 6 months after the second dose; boosters can bring effectiveness >90%. https://t.co/kqgwryJ1kT

— JAMA Network Open (@JAMANetworkOpen) February 3, 2023

The next generation of coronavirus vaccines: a graphical guide

3 Feb, 2023 | 14:18h | UTC

The next generation of coronavirus vaccines: a graphical guide – Nature

Review | Current and emerging knowledge of diagnostic imaging in COVID-19

2 Feb, 2023 | 15:04h | UTC

Current and Emerging Knowledge in COVID-19 – Radiology

The IDSA Guidelines on the diagnosis of COVID-19: antigen testing

1 Feb, 2023 | 13:37h | UTC

The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing – Clinical Infectious Diseases

Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US

1 Feb, 2023 | 13:36h | UTC

Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US – JAMA Network Open

News Release: COVID-19 is a leading cause of death in children and young people in the US – University of Oxford

Commentary: Expert reaction to study looking at children in the US aged 0 to 19 years whose underlying cause of death was COVID-19 – Science Media Centre

[Preprint] Risk of Hospitalization, severe disease, and mortality due to COVID-19 in children with SARS-CoV-2 infection in Germany – “overall hospitalization rate associated with SARS-CoV-2 infection was 35.9 per 10,000 children, ICU admission rate was 1.7 per 10,000 and case fatality was 0.09 per 10,000”.

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year – “In total, 99.995% of children and young people with a positive SARS-CoV-2 test survived”.

SR | Physical interventions to interrupt or reduce the spread of respiratory viruses

31 Jan, 2023 | 14:11h | UTC

Physical interventions to interrupt or reduce the spread of respiratory viruses – Cochrane Library

Commentary on Twitter (thread – click for more)

Just out Cochrane review on Physical interventions to interrupt or reduce the spread of respiratory viruses https://t.co/fI4Ac6VbAa

— Carl Heneghan (@carlheneghan) January 30, 2023

FDA panel eyes shift to annual COVID shots

30 Jan, 2023 | 01:03h | UTC

FDA panel eyes shift to annual COVID shots – CIDRAP

Case Series | Higher Troponin was associated with persistent cardiac MRI lesions in children with myocarditis after mRNA-based COVID-19 vaccination

30 Jan, 2023 | 01:01h | UTC

Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination – The Pediatric Infectious Disease Journal

Perspective | Were bivalent boosters worth it? The biggest questions about the newest Covid-19 vaccines are still unanswered

27 Jan, 2023 | 12:19h | UTC

Were bivalent boosters worth it? The biggest questions about the newest Covid-19 vaccines are still unanswered – Vox

SR | Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease

26 Jan, 2023 | 12:47h | UTC

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression – The Lancet Infectious Diseases

Editorial: The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era – The Lancet Infectious Diseases

News Release: University of Calgary and WHO researchers find hybrid immunity is the best protection against COVID-19

Commentaries:

Review finds hybrid immunity provides best protection against Omicron – CIDRAP

Hybrid Immunity Protects Better Against Hospitalisation and Severe COVID Infection – Health Policy Watch

Review | Spotlight on vaccine-induced thrombosis and thrombocytopenia (VITT)

26 Jan, 2023 | 12:46h | UTC

Spotlight on vaccine-induced thrombosis and thrombocytopenia (VITT) – Blood

M-A | Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years

25 Jan, 2023 | 11:26h | UTC

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis – JAMA Pediatrics

Editorial: COVID-19 Vaccines in Young Children—Reassuring Evidence for Parents – JAMA Pediatrics

Recommendations for the diagnosis and management of COVID-19 associated bacterial and fungal infections

20 Jan, 2023 | 14:48h | UTC

Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan – Journal of Microbiology, Immunology and Infection

Study shows low diagnostic sensitivities of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period

19 Jan, 2023 | 14:23h | UTC

Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period: a cross-sectional study – Clinical Microbiology and Infection

Commentary: Study: COVID-19 rapid home tests not highly sensitive for Omicron – CIDRAP

Cohort Study | Analysis of Rituximab use and COVID-19 hospitalization or death in patients with multiple sclerosis

19 Jan, 2023 | 14:22h | UTC

Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis – JAMA Network Open

Commentary on Twitter

Patients with MS on rituximab vaccinated for #COVID19 6 months before or after their last infusion had a much lower risk of COVID hospitalization – 1.4 vs 3.6 per 100 among unvaccinated people. https://t.co/am6hdSidMT

— JAMA Network Open (@JAMANetworkOpen) December 28, 2022

Stay Updated in Your Specialty